Remove Evidence Remove Healthcare Remove Pharmaceuticals
article thumbnail

AI in Pharmaceuticals: From Discovery to Market

Complex Discovery

Editor’s Note: Artificial intelligence (AI) is transforming the pharmaceutical industry, offering unprecedented opportunities to accelerate drug discovery, streamline clinical trials, and fortify intellectual property (IP) strategies.

article thumbnail

CAFC Reverses January Decision Affirming Sufficient Written Description for Negative Claim Limitation Over Judge Linn’s Dissent

IP Watchdog

Court of Appeals for the Federal Circuit issued a precedential decision in Novartis Pharmaceuticals Corp. Accord Healthcare, Inc. Earlier today, the U.S. granting a petition for rehearing from appellant HEC Pharm Co.,

article thumbnail

eDiscovery Vendor Voices in October 2024: The Rise of AI and Strategic Leadership Moves

Complex Discovery

As October 2024 concluded, it continues to be evident that the eDiscovery, cybersecurity, and information governance sectors are undergoing significant transformations. As AI becomes a critical tool in pharmaceutical innovation, it also presents challenges around data security, governance, and legal accountability. Read the update.